PMDA — authorised 26 July 2006
- Marketing authorisation holder: Otsuka Pharmaceutical Co., Ltd.
- Status: approved
🇯🇵 Physulime in Japan
PMDA authorised Physulime on 26 July 2006
Marketing authorisation
Physulime in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Hematology approved in Japan
Frequently asked questions
Is Physulime approved in Japan?
Yes. PMDA authorised it on 26 July 2006.
Who is the marketing authorisation holder for Physulime in Japan?
Otsuka Pharmaceutical Co., Ltd. holds the Japanese marketing authorisation.